7/103 sources · 3 publishersUpdated Oct 8, 21:48 UTC
Becton Dickinson to invest $3 billion in U.S. manufacturing, with over $1 billion earmarked for Nebraska
President Donald Trump announced that medical‑device maker Becton Dickinson will commit $3 billion to expand U.S. production of essential medical consumables. More than $1 billion of the funding will be directed to new facilities in Nebraska. BD’s CEO Tom Polen said the plan will increase domestic supply of syringes, needles and other products and will use American‑made steel for all U.S. needles.
Why it matters
The company says the investment will broaden its U.S. manufacturing capacity and reduce reliance on overseas suppliers, which could improve supply‑chain resilience for hospitals. No external analyst commentary was provided.
Key facts
- 1BD will invest $3 billion in U.S. manufacturing expansion. investing.com
- 2Over $1 billion of the investment will be allocated to Nebraska. investing.com
- 3BD plans to invest $19 billion in the United States over the coming years. oann.com
- 4The company aims to produce about 5 billion essential medical consumables annually. oann.com
- 5BD intends to manufacture 100% of its U.S. needles using American‑made steel. oann.com
Open questions
- The $19 billion total U.S. investment and the 5 billion consumables annual target are reported only by the OAN article and have not been confirmed by other sources.
Summary written by AlphAI from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.